NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 115 filers reported holding NURIX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,579,000 | -40.6% | 677,143 | -34.3% | 2.31% | -42.8% |
| Q1 2022 | $14,441,000 | -58.6% | 1,030,798 | -14.5% | 4.04% | -43.7% |
| Q4 2021 | $34,908,000 | -3.4% | 1,205,798 | 0.0% | 7.18% | +35.0% |
| Q3 2021 | $36,126,000 | +12.9% | 1,205,798 | 0.0% | 5.32% | +23.0% |
| Q2 2021 | $31,990,000 | -16.9% | 1,205,798 | -2.6% | 4.32% | -6.2% |
| Q1 2021 | $38,504,000 | -50.1% | 1,238,456 | -47.3% | 4.61% | -45.0% |
| Q4 2020 | $77,196,000 | -5.8% | 2,347,804 | -0.0% | 8.38% | -54.6% |
| Q3 2020 | $81,969,000 | – | 2,348,014 | – | 18.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 15,823 | $163,293 | 0.00% |